Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026)
Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 28.56% |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | -37.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.71% |
| Dec 31, 2025 | 44.61% |
| Sep 30, 2025 | -83.45% |
| Jun 30, 2025 | 37.36% |
| Mar 31, 2025 | -8.21% |
| Dec 31, 2024 | 0.57% |
| Sep 30, 2024 | 8.76% |
| Jun 30, 2024 | 38.26% |
| Mar 31, 2024 | -24.18% |
| Dec 31, 2023 | 296.66% |
| Sep 30, 2023 | -2.33% |
| Jun 30, 2023 | -30.67% |
| Mar 31, 2023 | 1,073.25% |
| Dec 31, 2022 | -56.80% |
| Sep 30, 2022 | 44.54% |
| Jun 30, 2022 | -40.04% |
| Mar 31, 2022 | 114.63% |
| Dec 31, 2021 | 159.80% |
| Sep 30, 2021 | 180.54% |
| Jun 30, 2021 | -78.39% |